Xiaobing Chen

1.7k total citations
87 papers, 1.2k citations indexed

About

Xiaobing Chen is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiaobing Chen has authored 87 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 25 papers in Oncology and 21 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiaobing Chen's work include Gastric Cancer Management and Outcomes (13 papers), RNA modifications and cancer (11 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Xiaobing Chen is often cited by papers focused on Gastric Cancer Management and Outcomes (13 papers), RNA modifications and cancer (11 papers) and Gastrointestinal Tumor Research and Treatment (7 papers). Xiaobing Chen collaborates with scholars based in China, United States and New Zealand. Xiaobing Chen's co-authors include Saiqi Wang, Huifang Lv, Beibei Chen, Bin Cheng, Bin Yu, Shuai Wang, Xiaohan Yuan, Wen Zhao, Zhi Wang and Yan Wu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Xiaobing Chen

81 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaobing Chen China 20 633 331 281 206 132 87 1.2k
Naoyo Nishida Japan 12 837 1.3× 401 1.2× 366 1.3× 140 0.7× 150 1.1× 27 1.5k
Zhe Liu China 20 659 1.0× 321 1.0× 328 1.2× 121 0.6× 148 1.1× 53 1.2k
Nidhi Gupta India 23 580 0.9× 302 0.9× 207 0.7× 93 0.5× 90 0.7× 72 1.3k
Wenhao Guo China 20 500 0.8× 237 0.7× 246 0.9× 166 0.8× 88 0.7× 30 1.0k
Malabika Sen United States 20 613 1.0× 526 1.6× 220 0.8× 192 0.9× 161 1.2× 43 1.2k
Qiu‐Xu Teng United States 25 932 1.5× 964 2.9× 261 0.9× 163 0.8× 108 0.8× 50 1.6k
Weidong Zhang China 17 948 1.5× 446 1.3× 271 1.0× 153 0.7× 154 1.2× 48 1.4k
Di Zhang China 22 938 1.5× 281 0.8× 375 1.3× 344 1.7× 116 0.9× 88 1.5k
Hui Tian China 20 626 1.0× 331 1.0× 193 0.7× 149 0.7× 82 0.6× 97 1.1k
Yue Cai China 21 463 0.7× 508 1.5× 162 0.6× 177 0.9× 153 1.2× 90 1.2k

Countries citing papers authored by Xiaobing Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaobing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobing Chen more than expected).

Fields of papers citing papers by Xiaobing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaobing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobing Chen. The network helps show where Xiaobing Chen may publish in the future.

Co-authorship network of co-authors of Xiaobing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaobing Chen. A scholar is included among the top collaborators of Xiaobing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaobing Chen. Xiaobing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Chunyan, et al.. (2025). A novel bispecific antibody CVL006 superior to AK112 for dual targeting of PD-L1 and VEGF in cancer therapy. PubMed. 8(3). 189–196. 1 indexed citations
2.
3.
4.
Wang, Hui, Caiyun Nie, Weifeng Xu, et al.. (2024). In era of immunotherapy: the value of trastuzumab beyond progression in patients with trastuzumab-resistant HER2-positive advanced or metastatic gastric cancer. Therapeutic Advances in Gastroenterology. 17. 1118428431–1118428431. 4 indexed citations
5.
6.
Liu, Bing, Xiaobing Chen, Yun Zhao, et al.. (2024). Inhibition of Glycolysis Alleviates Chronic Unpredictable Mild Stress Induced Neuroinflammation and Depression-like Behavior. Brain Sciences. 14(11). 1098–1098. 3 indexed citations
7.
Wang, Hui, Caiyun Nie, Huifang Lv, et al.. (2023). Novel GSH-responsive prodrugs derived from indole-chalcone and camptothecin trigger apoptosis and autophagy in colon cancer. Bioorganic Chemistry. 143. 107056–107056. 11 indexed citations
8.
Nie, Caiyun, Huifang Lv, Beibei Chen, et al.. (2023). High DCR and Better Survival in Patients with Advanced or Metastatic Gastric Cancer Receiving Anti-Angiogenic TKI plus Chemotherapy: A Real-World Study. Technology in Cancer Research & Treatment. 22. 2213892449–2213892449. 1 indexed citations
9.
Wang, Jianzheng, et al.. (2023). Comprehensive genomic profiling of small bowel adenocarcinoma by tissue and plasma biopsy. Genomics. 116(1). 110766–110766. 3 indexed citations
10.
Wang, Shuai, Xiaohan Yuan, Saiqi Wang, et al.. (2021). FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application. European Journal of Medicinal Chemistry. 214. 113218–113218. 108 indexed citations
11.
Wang, Bo, Xiaojing Li, Saiqi Wang, et al.. (2021). Discovery of a cinnamyl piperidine derivative as new neddylation inhibitor for gastric cancer treatment. European Journal of Medicinal Chemistry. 226. 113896–113896. 7 indexed citations
12.
Liu, Hongfei, Chenjun Zhang, Zhiping Zhang, et al.. (2020). Scandium Molybdate Nanofibers with Negative Thermal Expansion for Fabricating Composites with Controllable Coefficients of Thermal Expansion. ACS Applied Nano Materials. 3(7). 7130–7135. 6 indexed citations
13.
Li, Zan, et al.. (2020). Correlation between symptom groups and quality of life in patients with oral cancer after surgery. Zhonghua xiandai huli zazhi. 26(8). 1038–1043. 1 indexed citations
14.
Bie, Liangyu, Dan Li, Wei Yan, et al.. (2020). HOTAIR Competitively Binds MiRNA330 as a Molecular Sponge to Increase the Resistance of Gastric Cancer to Trastuzumab. Current Cancer Drug Targets. 20(9). 700–709. 14 indexed citations
15.
Li, Bin, Yan Cong, Jiamin Zhu, et al.. (2020). Anti–PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection–Related Advanced Hepatocellular Carcinoma: A Literature Review. Frontiers in Immunology. 11. 1037–1037. 65 indexed citations
16.
Hu, Qinchao, Tong Wu, Xiaobing Chen, et al.. (2018). The poor outcome of second primary oral squamous cell carcinoma is attributed to Bmi1 upregulation. Cancer Medicine. 7(4). 1056–1069. 16 indexed citations
17.
Chen, Xiaobing, et al.. (2013). Downregulation of BTG3 in non-small cell lung cancer. Biochemical and Biophysical Research Communications. 437(1). 173–178. 18 indexed citations
18.
Chen, Xiaobing. (2012). Establishment of the LC3 Recombinant Vector and Its Expression in Prokaryotic and Eukaryotic Cells. Biotechnology(Faisalabad). 2 indexed citations
19.
Chen, Xiaobing. (2012). Clinical observation of Oxaliplatin combined with Gimeracil or Capecitabine in the treatment of advanced gastric cancer in elderly patients. China Medical Herald. 2 indexed citations
20.
Xia, Juan, Xiumei Liu, Xiaoan Tao, et al.. (2009). Expression of gap junctional protein connexin43 during 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis. Journal of Molecular Histology. 40(3). 183–188. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Naoyo Nishida Breakdown of academic impact, for papers by Zhe Liu Breakdown of academic impact, for papers by Nidhi Gupta Breakdown of academic impact, for papers by Wenhao Guo Breakdown of academic impact, for papers by Malabika Sen Breakdown of academic impact, for papers by Qiu‐Xu Teng Breakdown of academic impact, for papers by Weidong Zhang Breakdown of academic impact, for papers by Di Zhang Breakdown of academic impact, for papers by Hui Tian Breakdown of academic impact, for papers by Yue Cai
Rankless by CCL
2026